Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers
Jun Li(Sun Yat-sen University), Yongjun Guo(Tianjin Agricultural University), Junnan Feng(Zhengzhou University), Sile Han(Zhengzhou University), Xinxin Wu(Shanghai Skin Disease Hospital), Hongle Li(Shanghai Jiao Tong University), Xiuli Yang(Shihezi University), Jie Ma(Kunming Medical University), Harry J.M. Groen(University Medical Center Groningen), Haiyan Zhang(Third Affiliated Hospital of Southern Medical University), Yi Wang(Hebei Medical University), Yuxi Chang(Zhengzhou University), Jiawen Zheng(Zhengzhou University), Cuiyun Zhang(Zhengzhou University), Bing Wei(Zhengzhou University), Anke van den Berg(University Medical Center Groningen)
Cited by 14
Related Papers
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
Metal-free alcohol-directed regioselective heteroarylation of remote unactivated C(sp3)–H bonds
|Nature Communications|2018|199
SETD2: an epigenetic modifier with tumor suppressor functionality
|Oncotarget|2016|167